ENST00000391728.8:c.809G>A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The ENST00000391728.8(KIR3DL1):​c.809G>A​(p.Arg270His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000653 in 1,608,412 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R270C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000093 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000062 ( 3 hom. )

Consequence

KIR3DL1
ENST00000391728.8 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: -0.842

Publications

3 publications found
Variant links:
Genes affected
KIR3DL1 (HGNC:6338): (killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1) Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.025999784).
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIR3DL1NM_013289.4 linkc.809G>A p.Arg270His missense_variant Exon 5 of 9 NP_037421.2 P43629-1Q5UCE2Q8N6C9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIR3DL1ENST00000391728.8 linkc.809G>A p.Arg270His missense_variant Exon 5 of 9 1 ENSP00000375608.4 P43629-1
KIR3DL1ENST00000326542.11 linkc.809G>A p.Arg270His missense_variant Exon 5 of 8 1 ENSP00000326868.7 W5QJC1
KIR3DL1ENST00000358178.4 linkc.524G>A p.Arg175His missense_variant Exon 4 of 8 1 ENSP00000350901.4 P43629-2

Frequencies

GnomAD3 genomes
AF:
0.0000926
AC:
14
AN:
151134
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000979
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000659
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.000634
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000736
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000124
AC:
19
AN:
153704
AF XY:
0.000168
show subpopulations
Gnomad AFR exome
AF:
0.0000842
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000683
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000625
AC:
91
AN:
1457164
Hom.:
3
Cov.:
35
AF XY:
0.0000745
AC XY:
54
AN XY:
724914
show subpopulations
African (AFR)
AF:
0.000210
AC:
7
AN:
33266
American (AMR)
AF:
0.0000448
AC:
2
AN:
44604
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25764
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39590
South Asian (SAS)
AF:
0.000617
AC:
53
AN:
85882
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53024
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5718
European-Non Finnish (NFE)
AF:
0.0000153
AC:
17
AN:
1109272
Other (OTH)
AF:
0.0000333
AC:
2
AN:
60044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000926
AC:
14
AN:
151248
Hom.:
0
Cov.:
32
AF XY:
0.0000677
AC XY:
5
AN XY:
73890
show subpopulations
African (AFR)
AF:
0.0000977
AC:
4
AN:
40962
American (AMR)
AF:
0.0000658
AC:
1
AN:
15198
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3444
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5152
South Asian (SAS)
AF:
0.000634
AC:
3
AN:
4730
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10546
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000736
AC:
5
AN:
67910
Other (OTH)
AF:
0.00
AC:
0
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000907
ExAC
AF:
0.000108
AC:
12

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 04, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.809G>A (p.R270H) alteration is located in exon 5 (coding exon 5) of the KIR3DL1 gene. This alteration results from a G to A substitution at nucleotide position 809, causing the arginine (R) at amino acid position 270 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Prostate cancer Uncertain:1
-
Science for Life laboratory, Karolinska Institutet
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
5.5
DANN
Benign
0.94
DEOGEN2
Benign
0.0019
T;.;.
Eigen
Benign
-1.8
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.00012
N
M_CAP
Benign
0.00046
T
MetaRNN
Benign
0.026
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.2
L;.;.
PhyloP100
-0.84
PROVEAN
Benign
-0.82
N;N;N
REVEL
Benign
0.050
Sift
Uncertain
0.0040
D;D;D
Sift4G
Benign
0.46
T;T;T
Polyphen
0.93
P;.;.
Vest4
0.067
MutPred
0.41
Loss of MoRF binding (P = 0.0121);Loss of MoRF binding (P = 0.0121);.;
MVP
0.067
MPC
2.1
ClinPred
0.0074
T
GERP RS
-2.9
Varity_R
0.13
gMVP
0.060
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs193921077; hg19: chr19-55333173; COSMIC: COSV58487843; API